Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China

Table 1 Baseline characteristics of participants

Variable	LS (n = 724)	CON (n = 363)	P value
Gender (M/F)	464/260	229/134	0.632
Age (yr)	39.9 ± 13.1	37.4 ± 18.2	0.221
Weight (kg)	88.5 ± 18.4	84.3 ± 21.8	0.711
Waist circumference (cm)	106.3 ± 23.2	108.8 ± 15.7	0.954
BMI	37.7 ± 12.7	38.4 ± 17.1	0.842
ALT (IU/L)	59.3 ± 20.1	58.3 ± 18.8	0.513
AST (IU/L)	57.8 ± 26.6	59.3 ± 12.9	0.182
GGT (IU/L)	61.3 ± 11.2	59.8 ± 19.6	0.215
Cholesterol (mmol/L)	5.7 ± 0.9	5.8 ± 1.1	0.167
Triglycerides (mmol/L)	2.4 ± 0.4	2.2 ± 0.6	0.094
Fasting glucose (mmol/L)	7.5 ± 1.3	7.4 ± 1.6	0.332
Fasting insulin (μIU/mL)	17.7 ± 4.3	19.5 ± 5.7	0.185
HOMA-IR	2.4 ± 0.7	2.3 ± 0.9	0.231
L/S ratio	0.8 ± 0.3	0.7 ± 0.2	0.423
VFA, cm2	135.6 ± 38.7	138.9 ± 39.4	0.172
Diabetes (%)	66 (6.1)	62 (5.7)	0.876
Metabolic syndrome (%)	201 (18.5)	186 (17.1)	0.563

Data as percentage or mean ± SE. BMI: Body mass index; ALT: Alanine transaminase; AST: Aspartate transaminase; GGT: γ-glutamyltransferase; HOMA-IR: Homeostasis model assessment of insulin resistance; VFA: Visceral fat area; L/S: Liver-spleen.